Colony formation ability was then assessed in azathioprine-treated CML mice and controls, and the results showed that azathioprine dramatically reduced the colony formation ability of the BCR-ABL-driven CML BMCs (Figure 6F). The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.